Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

L1 retrotransposon antisense RNA within ASAR lncRNAs controls chromosome-wide replication timing.

Platt EJ, Smith L, Thayer MJ.

J Cell Biol. 2018 Feb 5;217(2):541-553. doi: 10.1083/jcb.201707082. Epub 2017 Dec 29.

2.

Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1.

Platt EJ, Durnin JP, Kabat D.

AIDS Res Hum Retroviruses. 2015 Oct;31(10):992-8. doi: 10.1089/AID.2015.0131. Epub 2015 Aug 5.

3.

Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Ritchie C, Cylinder I, Platt EJ, Barklis E.

J Virol. 2015 Apr;89(7):3988-4001. doi: 10.1128/JVI.03584-14. Epub 2015 Jan 28.

4.

Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.

Platt EJ, Gomes MM, Kabat D.

J Virol. 2014 Apr;88(8):4304-18. doi: 10.1128/JVI.03447-13. Epub 2014 Jan 29.

5.

Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.

Platt EJ, Gomes MM, Kabat D.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7829-34. doi: 10.1073/pnas.1109728109. Epub 2012 Apr 30.

6.
7.

Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.

Platt EJ, Bilska M, Kozak SL, Kabat D, Montefiori DC.

J Virol. 2009 Aug;83(16):8289-92. doi: 10.1128/JVI.00709-09. Epub 2009 May 27.

8.
10.

CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18.

Golding H, Khurana S, Yarovinsky F, King LR, Abdoulaeva G, Antonsson L, Owman C, Platt EJ, Kabat D, Andersen JF, Sher A.

J Biol Chem. 2005 Aug 19;280(33):29570-7. Epub 2005 Jun 23.

13.

Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.

Madani N, Millette R, Platt EJ, Marin M, Kozak SL, Bloch DB, Kabat D.

J Virol. 2002 Nov;76(21):11133-8.

15.

Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.

Kuhmann SE, Madani N, Diop OM, Platt EJ, Morvan J, Müller-Trutwin MC, Barré-Sinoussi F, Kabat D.

J Virol. 2001 Sep;75(18):8449-60.

16.
17.

Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1.

Platt EJ, Kozak SL, Kabat D.

AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):871-82.

PMID:
10875613
18.
19.
21.

Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.

Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, Kabat D, Chesebro B, Goldsmith MA.

J Virol. 1997 Sep;71(9):7136-9.

22.
23.
25.

Differential transport and processing of variant mouse mammary tumor virus glycoproteins.

Platt EJ, Kain SR, Goodman LJ, Firestone GL.

J Cell Biochem. 1992 Aug;49(4):425-37.

PMID:
1331125
29.

Highly sensitive immunoadsorption procedure for detection of low-abundance proteins.

Platt EJ, Karlsen K, Lopez-Valdivieso A, Cook PW, Firestone GL.

Anal Biochem. 1986 Jul;156(1):126-35.

PMID:
3017145
30.

Morphine studies; 2-(2',3'-dimethoxyphenyl)-2-(beta-ethoxyethyl)-cyclohexanone.

HORNING EC, HORNING MG, PLATT EJ.

J Am Chem Soc. 1948 Jun;70(6):2072-5. No abstract available.

PMID:
18863799
31.

Morphine studies; the phenanthrene unit.

HORNING EC, HORNING MG, PLATT EJ.

J Am Chem Soc. 1947 Dec;69(12):2929-32. No abstract available.

PMID:
18919695

Supplemental Content

Loading ...
Support Center